Page last updated: 2024-08-23

daunorubicin and Cardiomyopathy, Hypertrophic

daunorubicin has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ezaki, K; Hirano, M; Ino, T; Miyazaki, H; Okamoto, M; Tsuzuki, M	1

Other Studies

1 other study(ies) available for daunorubicin and Cardiomyopathy, Hypertrophic

Article	Year
[Long-term selective beta 1-blockade therapy for a patient with anthracycline-induced cardiomyopathy]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:11 Topics: Aclarubicin; Adrenergic beta-Antagonists; Adult; Antibiotics, Antineoplastic; Cardiomyopathy, Hypertrophic; Chronic Disease; Daunorubicin; Drug Administration Schedule; Female; Heart Failure; Humans; Leukemia, Myelomonocytic, Acute; Metoprolol; Mitoxantrone	1995

Article

Year

[Long-term selective beta 1-blockade therapy for a patient with anthracycline-induced cardiomyopathy].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:11

Topics: Aclarubicin; Adrenergic beta-Antagonists; Adult; Antibiotics, Antineoplastic; Cardiomyopathy, Hypertrophic; Chronic Disease; Daunorubicin; Drug Administration Schedule; Female; Heart Failure; Humans; Leukemia, Myelomonocytic, Acute; Metoprolol; Mitoxantrone

1995